To include your compound in the COVID-19 Resource Center, submit it here.

Kiobrina: Phase III data

Top-line data from the double-blind, European Phase III LAIF study in 410 preterm infants <32 weeks of gestational age showed that Kiobrina added to preterm formula or pasteurized breast milk missed

Read the full 315 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE